EDGAR Filing Documents for 0001140361-24-035951

Form 8-K - Current report:

SEC Accession No. 0001140361-24-035951

Filing Date

2024-08-06

Accepted

2024-08-06 17:27:45

Documents

Period of Report

2024-08-05

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	ny20030749x1_8k.htm iXBRL	8-K	89711
2	EXHIBIT 2.1	ny20030749x1_ex2-1.htm	EX-2.1	724698
3	EXHIBIT 10.1	ny20030749x1_ex10-1.htm	EX-10.1	115335
4	EXHIBIT 10.2	ny20030749x1_ex10-2.htm	EX-10.2	780957
5	EXHIBIT 10.3	ny20030749x1_ex10-3.htm	EX-10.3	140496
6	EXHIBIT 10.4	ny20030749x1_ex10-4.htm	EX-10.4	85377
7	EXHIBIT 99.1	ny20030749x1_ex99-1.htm	EX-99.1	91734
8	EXHIBIT 99.2	ny20030749x1_ex99-2.htm	EX-99.2	101790
	Complete submission text file	0001140361-24-035951.txt		2627713

Data Files

Seq	Description	Document	Type	Size
9	XBRL TAXONOMY EXTENSION SCHEMA	mcrb-20240805.xsd	EX-101.SCH	3892
10	XBRL TAXONOMY EXTENSION LABEL LINKBASE	mcrb-20240805_lab.xml	EX-101.LAB	21966
11	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	mcrb-20240805_pre.xml	EX-101.PRE	16062
24	EXTRACTED XBRL INSTANCE DOCUMENT	ny20030749x1_8k_htm.xml	XML	4069

Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139

Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626

Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)